Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Early Ultrasound and Maternal Biochemical Markers to Evaluate the Risk of Down Syndrome During the First Trimester

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT00287417
First received: September 13, 2005
Last updated: May 13, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2011
  Estimated Primary Completion Date: No date given